Esophageal Diseases  >>  Teysuno (gimeracil/oteracil/tegafur)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
NCT01824459: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

Completed
3
576
RoW
S-1, Oxaliplatin, Cisplatin
Sun Yat-sen University, Taiho Pharmaceutical Co., Ltd.
Gastric Cancer
12/18
12/18
NCT01704690: Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Terminated
2/3
4
RoW
S-1 and Paclitaxel, TEYSUNO, TAXOL, Paclitaxel and Cisplatin, PLATINOL, 5-FU and Cisplatin, 5-fluorouracil
Peking University
Esophageal Cancer
03/17
03/17

Download Options